SCHEMBL22679281

SCHEMBL22679281

Cc1ccc(-c2ccccc2)cc1-c1cc2c3ccccc3n3c4ccc5ccccc5c4c(c1)c23

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.35
TSPO P30536 1/20 0.34
NPY5R Q15761 1/20 0.32
FLT3 P36888 1/20 0.32
CYP1A2 P05177 2/20 0.32
SLC6A2 P23975 2/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LCK P06239 1/20 0.32
FYN P06241 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ACHE P22303 1/20 0.32
AHR P35869 1/20 0.32
CYP2A6 P11509 1/20 0.31
TSHR P16473 1/20 0.31
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA9 Q16790 2/20 0.31
CHRNA1 P02708 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21718133 0.90 PTGER4 (0.33) PTGESTSPO
SCHEMBL21710591 0.89 PTGES (0.33) PTGESTSPONPY5RFLT3CYP1A2
SCHEMBL21710576 0.88 TSPO (0.38) TSPONPY5RMAPTKDM4EMAOB
SCHEMBL21710472 0.87 PTGES (0.38) PTGESTSPONPY5RCYP1A2MAPT
SCHEMBL21710705 0.85 PTGES (0.36) PTGESTSPONPY5RCYP1A2MAPT
SCHEMBL21718129 0.85 TSPO (0.37) PTGESTSPONPY5RFLT3CYP1A2
SCHEMBL21710645 0.85 NPY5R (0.36) TSPONPY5RFLT3CYP1A2MAPT
SCHEMBL22858082 0.84 KDM4E (0.36) PTGESCYP1A2SLC6A2MAPTALDH1A1
SCHEMBL21710477 0.84 PTGES (0.34) PTGESTSPOCYP1A2MAPTALDH1A1
SCHEMBL21710474 0.84 PTGES (0.35) PTGESTSPONPY5RCYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 PTGES 4031/4885TSPO 1545/4885NPY5R 4059/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 PTGES 4447/4885TSPO 789/4885NPY5R 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.